Flow-cytometry Based Services

• Quantitative analysis of receptors upon drug treatment
• Validation and evaluation studies for receptor expression
• Real time measurement of ligand-receptor interactions
• Drug discovery/screening based on G Protein-coupled Receptors (GPCRs) expression
• Cell cycle analysis
• Gene/protein expression studies
  • Cancer Marker Detection:
    A2B1, A2B5, A6 integrin, ALDH, CD340/HER-2 Neu, CD5, CD9, CD13, CD19, CD20, CD23, CD24, CD34, CD34/CXCR4, CD44, CD63, CD133, CD177, CXCR4, CD151, CD164, EpCAM, ER, Nestin, PR-A & B and others.
  • CD4/CD8 T-cell count and soluble HIV antigen detections
  • Circulating EPC(endothelail progenitor cells) precussors
  • Activated platelet identification
  • HLA-B27 detection in spondylo arthropathies
  • Exclusive CD34 cell count from total blood